Financial Statements/ESG Information - [Interim/Half-Year Report]

Broncus Holding Corporation offers medical services. The Company provides lung access navigation, lung disease diagnosis, lung disease treatment and other services. Broncus Holding provides its services throughout Hong Kong.

Interim Report 2024

Announcements and Notices - [Interim Results]

Announcement Of Interim Results
For The Six Months Ended June 30, 2024

Announcements and Notices - [Other - Miscellaneous]

Voluntary Announcement - Change Of Registered Address Of A Subsidiary; Addition Of
Principal Place Of Business Of The Group In China

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Change in Company Secretary / Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Broncus (2216 HK)

Interim Report 2024

Announcement Of Interim Results For The Six Months Ended June 30, 2024

Voluntary Announcement - Change Of Registered Address Of A Subsidiary; Addition Of Principal Place Of Business Of The Group In China

Date Of Board Meeting

Change Of Company Secretary, Process Agent And Authorized Representative

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)